IDDM
HF
A-FIB
DRUGS
NURSING
100

Blood Glucose

Normal range: 

4-8 mmol/L

100

Laboratory Test

B-type Natriuretic Peptide (BNP)

100

Arrythmia

Pulse: irregular, fast, weak

100

Oral Hypoglycemics

Metformin: reduces available sugar for absorption

Glyburide: increases pancreas insulin release

100

Hypoglycemia Protocol

PO/dysphagia/NPO

Conscious vs. Unconscious

200

Blood Tests

Acute: blood glucose level

Chronic: Hemoglobin A1C

200

Right-Sided HF

Peripheral Edema

Weight Gain

200

Health Risk

Decreased cardiac output.

Blood stasis & clot formation.

200

Insulins

Rapid-acting (Lispro)

Fast-acting (Humulin R)

Long-acting (Lantus/glargine)

200

Diabetic Diet

Complex carbohydrates

Low-fat proteins

300

Long-Term Complications

Neuropathy (peripheral nerves)

Nephropathy (kidney damage)

Retinopathy (vision changes)

300

Left-Sided HF

Pulmonary Edema

Dyspnea/SOB

300

Cardiac Tests

ECG

Holter Monitor

Echocardiogram

300

Diuretics

Furosemide: hypokalemia

Spironolactone: hyperkalemia

300

Sliding Scale

Type of insulin

Frequency/timing

CBG Parameters

400

Foot Care

Protect feet, inspect skin, treat wounds, remove necrosis, amputation surgery. 

400

Blood Pressure

Early: hypertension

Advanced: hypotension

400

Laboratory Tests

Coagulation: INR, PTT

Electrolytes: Na+, K+, Ca+

400

Anticoagulants

Warfarin: po, frequent INR, monitor bleeding

Apixaban: po, monitor bleeding

400

SBAR

Reportable findings: new, urgent, unsafe, significant

500

Hypoglycemia

Day/night fluctuations

Medication effect

Nutrition changes

500

Lifestyle

Low exertion activities

Low sodium diet

Oxygen therapy

500

Bradycardia

Medication effect

Worsening heart function

Disease progression

500

Antiarrhythmics

Digoxin: narrow therapeutic index, toxicity, bradycardia, visual changes

500

Discharge Planning

Patient education effective

Rx covered by health benefits

M
e
n
u